Ramsay Health Care share price pushes higher following FY 2020 results

The Ramsay Health Care Limited (ASX:RHC) share price is pushing higher on Thursday after releasing its full year results…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price is pushing higher on Thursday following its full year results release.

At the time of writing the private hospital operator's shares are up 1.5% to $66.45.

How did Ramsay perform in FY 2020?

It was a tough year for Ramsay because of the negative impact of the pandemic on elective surgeries and costs.

During the 12 months ended 30 June 2020, Ramsay posted a solid 7.3% increase in revenue up 7.3% to $12.4 billion.

However, this revenue increase didn't flow through to its earnings. Ramsay recorded a 7% decline in earnings before interest, taxes, depreciation, amortisation, and restructuring or rent costs (EBITDAR) to $2 billion.

Things were even worse on the bottom line, with the company posting a 43% decline in core net profit after tax to $336.9 million. This was down 34.4% on a like for like basis.

In light of this sizeable profit decline and the tough operating environment, as previously announced, Ramsay has decided against paying a final dividend.

How did its segments perform?

Ramsay's core Australia/Asia business reported a 2.2% decline in revenue to $5.1 billion and a 23.2% reduction in EBITDAR to $781.3 million.

Over in the UK, Ramsay recorded a 4.9% decline in revenue to 494.8 million pounds and a 10.6% fall in EBITDAR to 89.2 million pounds.

Things were better in Continental Europe due to its recent acquisitions. It recorded a 14.3% lift in revenue to 3.9 billion euros and an 8.5% increase in EBITDAR to 641.1 million euros.

A tale of two halves.

Ramsay Health Care's Managing Director, Craig McNally, notes that the company was on track for growth until the end of February.

He commented: "At our interim results we reaffirmed our FY'20 guidance of core EPS growth on a like for like basis of 2% to 4%. However, the extraordinary circumstances posed by the COVID-19 pandemic on the Company's operations around the world resulted in us withdrawing guidance in March 2020 and had a significant impact on the full year result."

Mr McNally notes that elective surgery restrictions were imposed in most regions from March 2020 creating a significant level of uncertainty. Combined with increasing costs, this weighed heavily on its results.

Speaking about the costs, the managing director commented: "We are also experiencing additional costs associated with increased PPE usage, more costly PPE on a per unit basis, social distancing requirements, staff costs involved in screening patients, staff and visitors, and increased cleaning regimes."

Outlook.

Given that many uncertainties remain with respect to the ongoing impact of the pandemic, Ramsay was unable to provide financial guidance for FY 2021.

Nevertheless, the company remains positive on its long term outlook.

Mr McNally commented: "Notwithstanding the significant near-term uncertainties, over the longer term, strong industry fundamentals remain. In addition to the increased demand for healthcare generally created by ageing populations with increased incidence of chronic disease, there are also now longer public waiting lists in each of our markets. We expect to play an enhanced role in relieving pressure on public waiting lists into the future."

The managing director also revealed that the company continues to look at expanding its network at home and abroad.

"Following our recent $1.5 billion equity raising, Ramsay is also committed to expanding our business both in Australia and overseas, in and out of hospital where there is a strategic fit and it meets our strict investment criteria. We have a strong balance sheet to support this growth strategy," he concluded.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »